Literature DB >> 11712790

Impact of hepatitis B and C virus infection on the clinical prognosis of alcoholic liver cirrhosis.

T Yamanaka1, K Shiraki, S Nakazaawa, H Okano, T Ito, M Deguchi, K Takase, T Nakano.   

Abstract

To elucidate the rates of appearance of hepatocellular carcinoma (HCC) and the prognosis of alcoholic liver cirrhosis upon infection with hepatitis virus, we retrospectively studied 190 consecutive patients. The patients were divided into three groups based on whether they were exposed either to hepatitis B virus (HBV), hepatitis C virus (HCV) or not. The cumulative survival rate of the alcoholic liver cirrhosis patients with hepatitis B surface antigen (HBsAg) was significantly lower than that in those with hepatitis C antibody (anti-HCV). Most alcoholic liver cirrhosis patients without hepatitis virus infection died of liver failure, gastrointestinal (G1) bleeding, or other diseases. However, alcoholic liver cirrhosis patients with anti-HCV tended to die of HCC. The cumulative HCC appearance rate in alcoholic liver cirrhosis patients without HBsAg or anti-HCV was 7% at the end of the fifth year after the diagnosis of cirrhosis and 15% at the end of the tenth year. However; the HCC appearance rate was about 20% at the end of the fifth year after the diagnosis of cirrhosis and about 50% at the end of the tenth year in both alcohol drinkers with HBsAg or anti-HCV. These data suggest that hepatitis virus infection may modify the prognosis for alcoholic liver cirrhosis patients, especially in the development of carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11712790

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

1.  The alteration of PTEN tumor suppressor expression and its association with the histopathological features of human primary hepatocellular carcinoma.

Authors:  X-W Wan; M Jiang; H-F Cao; Y-Q He; S-Q Liu; X-H Qiu; M-C Wu; H-Y Wang
Journal:  J Cancer Res Clin Oncol       Date:  2003-03-07       Impact factor: 4.553

2.  Liver transplantation for alcoholic liver disease.

Authors:  Vibha Varma; Kerry Webb; Darius F Mirza
Journal:  World J Gastroenterol       Date:  2010-09-21       Impact factor: 5.742

Review 3.  Management of alcohol misuse in patients with liver diseases.

Authors:  Jennifer L Peng; Milan Prakash Patel; Breann McGee; Tiebing Liang; Kristina Chandler; Sucharat Tayarachakul; Sean O'Connor; Suthat Liangpunsakul
Journal:  J Investig Med       Date:  2016-12-09       Impact factor: 2.895

4.  Effect of alcohol on clinical complications of hepatitis virus-induced liver cirrhosis: a consecutive ten-year study.

Authors:  Kodjo-Kunale Abassa; Xiao-Ying Wu; Xiu-Ping Xiao; Hao-Xiong Zhou; Yun-Wei Guo; Bin Wu
Journal:  BMC Gastroenterol       Date:  2022-03-19       Impact factor: 3.067

5.  Association of Heavy Alcohol Intake and ALDH2 rs671 Polymorphism With Hepatocellular Carcinoma and Mortality in Patients With Hepatitis B Virus-Related Cirrhosis.

Authors:  Ming-Chao Tsai; Sien-Sing Yang; Chih-Che Lin; Wen-Lun Wang; Yao-Chun Hsu; Yaw-Sen Chen; Jui-Ting Hu; James Yu Lin; Ming-Lung Yu; Chih-Wen Lin
Journal:  JAMA Netw Open       Date:  2022-07-01

Review 6.  Advancements in the Alcohol-Associated Liver Disease Model.

Authors:  Lin Zhu; Hai-Di Li; Jie-Jie Xu; Juan-Juan Li; Miao Cheng; Xiao-Ming Meng; Cheng Huang; Jun Li
Journal:  Biomolecules       Date:  2022-07-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.